Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
No subjects enrolled
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Medtronic | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| OptivolĀ® Device in CareLink | A single cohort group of heart failure patients with already implanted OptivolĀ® capable devices who are discharged home from the hospital |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Physician Use of Cardiac Compass Reports to Determine HF Treatment Decisions | Assessment will be completed at time of enrollment and days 3 to 7, 14 to 21, 30 and 90 post discharge. | 90 days from enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Heart Failure Clinical Events | Track HF re-admissions and other clinical encounters between 30 and 90 days post discharge for HF. | 90 days from enrollment |
| Assess Patient-Reported Quality of Life |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
hospital inpatients
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David J Whellan, MD MHS | Thomas Jefferson University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | United States |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Assess the association between the use of Cardiac Compass Report and OptiVolĀ® and improved HF patient quality of life at both time points (30 and 90 days post discharge) utilizing the Kansas City Cardiomyopathy Questionnaire (KCCQ)
| 90 days from enrollment |